SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Tretli S)
 

Sökning: WFRF:(Tretli S) > Metabolic syndrome ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004402naa a2200649 4500
001oai:DiVA.org:umu-42228
003SwePub
008110406s2011 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:0fc2029c-851c-4a3a-90fb-7f3e852ed4b0
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-422282 URI
024a https://doi.org/10.1093/annonc/mdq5972 DOI
024a https://lup.lub.lu.se/record/19856412 URI
040 a (SwePub)umud (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Nagel, G4 aut
2451 0a Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)
264 1b Oxford Journals,c 2011
338 a print2 rdacarrier
520 a BACKGROUND: Risk factors for rare gynecological cancers are largely unknown. Initial research has indicated that the metabolic syndrome (MetS) or individual components could play a role. Materials and methods: The Metabolic syndrome and Cancer project cohort includes 288 834 women. During an average follow-up of 11 years, 82 vulvar, 26 vaginal and 43 other rare gynecological cancers were identified. Hazard ratios (HRs) were estimated fitting Cox proportional hazards regression models for tertiles and standardized z-scores [with a mean of 0 and a standard deviation (SD) of 1] of body mass index (BMI), blood pressure, glucose, cholesterol, triglycerides and MetS. Risk estimates were corrected for random error in the measurement of metabolic factors. RESULTS: The MetS was associated with increased risk of vulvar [HR 1.78, 95% confidence interval (CI) 1.30-2.41) and vaginal cancer (HR 1.87, 95% CI 1.07-3.25). Among separate MetS components, 1 SD increase in BMI was associated with overall risk (HR 1.43, 95% CI 1.23-1.66), vulvar (HR 1.36, 95% CI 1.11-1.69) and vaginal cancer (HR 1.79, 95% CI 1.30-2.46). Blood glucose and triglyceride concentrations were associated with increased risk of vulvar cancer (HR 1.98, 95% CI 1.10-3.58 and HR 2.09, 95% CI 1.39-3.15, respectively). CONCLUSION: The results from this first prospective study on rare gynecological cancers suggest that the MetS and its individual components may play a role in the development of these tumors.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a epidemiology
653 a MetS
653 a rare gynecological cancers
653 a Oncology
653 a Onkologi
653 a onkologi
653 a Oncology
653 a epidemiology
653 a MetS
653 a rare gynecological cancers
700a Concin, H4 aut
700a Bjørge, T4 aut
700a Rapp, K4 aut
700a Manjer, Jonasu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups4 aut0 (Swepub:lu)smi-jma
700a Hallmans, Göranu Umeå universitet,Näringsforskning4 aut0 (Swepub:umu)goha0001
700a Diem, G4 aut
700a Häggström, Christelu Umeå universitet,Urologi och andrologi4 aut0 (Swepub:umu)chlham02
700a Engeland, A4 aut
700a Almquist, Martinu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups4 aut0 (Swepub:lu)kir-mal
700a Jonsson, Håkanu Umeå universitet,Onkologi4 aut0 (Swepub:umu)hojo0001
700a Selmer, R4 aut
700a Stocks, Tanjau Umeå University,Umeå universitet,Urologi och andrologi4 aut0 (Swepub:lu)med-tss
700a Tretli, S4 aut
700a Ulmer, H4 aut
700a Stattin, Päru Umeå universitet,Urologi och andrologi4 aut0 (Swepub:umu)past0003
700a Lukanova, A4 aut
710a Kirurgib Forskargrupper vid Lunds universitet4 org
773t Annals of Oncologyd : Oxford Journalsg 22:6, s. 1339-1345q 22:6<1339-1345x 0923-7534x 1569-8041
856u https://doi.org/10.1093/annonc/mdq597
856u http://dx.doi.org/10.1093/annonc/mdq597y FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-42228
8564 8u https://doi.org/10.1093/annonc/mdq597
8564 8u https://lup.lub.lu.se/record/1985641

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy